These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 35281438)

  • 21. In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020.
    Lee YL; Ko WC; Lee WS; Lu PL; Chen YH; Cheng SH; Lu MC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Shao PL; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2021 Sep; 58(3):106377. PubMed ID: 34166777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
    Debnath A; Pillinger KE; Martin AJ; Dobrzynski D; Cameron A; Shulder S
    Ann Pharmacother; 2023 Jul; 57(7):803-812. PubMed ID: 36268974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: a multicentre study.
    Salmanov A; Shchehlov D; Svyrydiuk O; Bortnik I; Mamonova M; Korniyenko S; Rud V; Artyomenko V; Gudym M; Maliarchuk R; Bondar T
    J Hosp Infect; 2023 Jan; 131():129-138. PubMed ID: 36306892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran.
    Askarian M; Yadollahi M; Assadian O
    J Infect Public Health; 2012 Apr; 5(2):169-76. PubMed ID: 22541264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active Surveillance of Healthcare-associated Infections in Pediatric Intensive Care Units: Multicenter ECDC HAI-net ICU Protocol (v2.2) Implementation, Antimicrobial Resistance and Challenges.
    Briassoulis P; Briassoulis G; Christakou E; Machaira M; Kassimis A; Barbaressou C; Nikolaou F; Sdougka M; Gikas A; Ilia S
    Pediatr Infect Dis J; 2021 Mar; 40(3):231-237. PubMed ID: 33565812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.
    Hidron AI; Edwards JR; Patel J; Horan TC; Sievert DM; Pollock DA; Fridkin SK; ;
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):996-1011. PubMed ID: 18947320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India.
    Kumar S; Sen P; Gaind R; Verma PK; Gupta P; Suri PR; Nagpal S; Rai AK
    Am J Infect Control; 2018 Feb; 46(2):202-206. PubMed ID: 29046215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant
    Lim FK; Liew YX; Cai Y; Lee W; Teo JQM; Lay WQ; Chung J; Kwa ALH
    Front Cell Infect Microbiol; 2020; 10():579462. PubMed ID: 33178629
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
    Teo J; Cai Y; Tang S; Lee W; Tan TY; Tan TT; Kwa AL
    PLoS One; 2012; 7(3):e34254. PubMed ID: 22461908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.
    Weiner-Lastinger LM; Abner S; Benin AL; Edwards JR; Kallen AJ; Karlsson M; Magill SS; Pollock D; See I; Soe MM; Walters MS; Dudeck MA
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):19-30. PubMed ID: 31762428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.
    Su LH; Chen IL; Tang YF; Lee JS; Liu JW
    PLoS One; 2020; 15(5):e0233265. PubMed ID: 32421700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic consumption and healthcare-associated infections caused by multidrug-resistant gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship.
    Chen IL; Lee CH; Su LH; Tang YF; Chang SJ; Liu JW
    PLoS One; 2013; 8(5):e65621. PubMed ID: 23738018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece.
    Kritsotakis EI; Kontopidou F; Astrinaki E; Roumbelaki M; Ioannidou E; Gikas A
    Infect Drug Resist; 2017; 10():317-328. PubMed ID: 29066921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching.
    Kwon KT; Kim Y; Kim SW; Chang HH; Hwang S; Bae S; Nam E
    J Korean Med Sci; 2024 Apr; 39(14):e132. PubMed ID: 38622938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.
    Weiner LM; Webb AK; Limbago B; Dudeck MA; Patel J; Kallen AJ; Edwards JR; Sievert DM
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1288-1301. PubMed ID: 27573805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China.
    Gong X; Zhang J; Su S; Fu Y; Bao M; Wang Y; Zhang X
    BMC Infect Dis; 2018 Aug; 18(1):417. PubMed ID: 30134844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excess mortality and long-term disability from healthcare-associated carbapenem-resistant Acinetobacter baumannii infections: A nationwide population-based matched cohort study.
    Su CH; Chien LJ; Fang CT; Chang SC
    PLoS One; 2023; 18(9):e0291059. PubMed ID: 37695791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for in-hospital acquisition of carbapenem-resistant Enterobacterales in patients with severe burns.
    Han SB; Jeon K; Kim M; Park J; Yoon J; Cho YS; Hur J; Chun W; Kym D
    J Hosp Infect; 2024 Jul; 149():165-171. PubMed ID: 38740304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
    Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
    J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study.
    Walker MK; Diao G; Warner S; Babiker A; Neupane M; Strich JR; Yek C; Kadri SS;
    Lancet Infect Dis; 2024 Aug; 24(8):856-867. PubMed ID: 38679036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.